Exosome Diagnostics and Treatment Market is expected to reach US$ 358.91 million in 2027

by Sameer Joshi or 24-Apr-2020
     Request For Sample

Report : Exosome Diagnostics and Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing & Targeted Sequencing, Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users)

Instrument Segment to DriveGrowth of Global Exosome Diagnostic and Therapeutic Market,by Product

According to a new market research study of “Exosome Diagnostic and Therapeutic Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Application, Product, and End User,”the global exosome diagnostic and therapeutic market is projectedto reach US$ 358.91 million thousandby2027 from US$ 41.6.33 million 2019; it is estimated to grow ata CAGR of 32.2% from 2020 to 2027. The report highlights trends prevailing in the global exosome diagnostic and therapeutic market and the factors driving market along with those that act as hindrances.

Exosomes are distinct populations of tiny membranous vesicles, released into the extracellular space by most cells, which get eventually accumulated in the body fluid circulation. By acting as cellular messengers, they play a role in vital physiological functions by transporting information between different cell types. These tiny particles carry cellular nucleic acids and proteins from their host cells to target cells, which represent the comprehensive information about pathophysiological conditions of the host cell. For instance, exosomes released from tumor cells contains tumor-specific RNAs that can be potentially detected during cancer diagnosis.

The global exosome diagnostic and therapeutic market, based on product, isfurther segmented intoinstruments, reagents, and software.In 2019, the instrumentssegment accounted for the largest share ofthe global exosome diagnostic and therapeutic market. However, the software segment is expected to grow at the highest rateduring the forecast period. The instrumentssegment is expected to grow owing to wide applications of exosome instruments in the diagnosis of chronic diseases. Moreover, increasing adoption of instruments for the diagnostic applications and gradually increasing demand for novel diagnostic procedures are also likely to offer significant opportunity for the growth of the market.

Leading companies operating in the exosome diagnostic and therapeutic market are Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, NorgenBiotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and MiltenyiBiotec, among others.
 

The report segments global exosome diagnostic and therapeutic market as follows:
ByApplication

  •  Diagnostic
  •  Therapeutic

By Product

  •  Instruments
  •  Reagents
  •  Software

By End User

  •  Cancer Institutes
  •  Hospitals
  •  Diagnostic Centers
  •  Others

By Geography

  •  North America
    •  US
    •  Canada
    •  Mexico
  •  Europe
    •  France
    •  Germany
    •  UK
    •  Spain
    •  Italy
  •  Asia Pacific (APAC)
    •  China
    •  India
    •  Japan
    •  Australia
    •  South Korea
  •  Middle East & Africa (MEA)
    •  Saudi Arabia
    •  UAE
    •  South Africa
  •  South & Central America (SCAM)
    •  Brazil
    •  Argentina

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com